📰 Apa News
Page 16 - Apa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Apa. Real-time updates on events, politics, business and more.
May 5, 2024
New literature review data suggests doxazosin is related to less incident hypotension than prazosin, while providing clinical benefit, in PTSD patients with condition-related nightmares.
May 5, 2024
Kane explains why newer long-acting injectables and clozapine may be under-utilized still in the management of schizophrenia.
May 5, 2024
Marmar explains what anticipated blood and molecular profiling of PTSD may provide psychiatrists treating patients.
May 5, 2024
Devanand reviews lecanemab and the advent of blood biomarkers for dementia and Alzheimer's management at APA 2024.
May 4, 2024
APA (NASDAQ:APA – Free Report) had its price objective decreased by Barclays from $40.00 to $38.00 in a research note released on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. Other equities analysts also recently issued reports about the stock. Morgan Stanley restated an underweight rating and set a […]
May 4, 2024
APA (NASDAQ:APA – Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.12), Briefing.com reports. APA had a net margin of 34.04% and a return on equity of 45.32%. The business had revenue of $1.95 billion for […]
May 4, 2024
Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder.
May 3, 2024
Jane Mead loved nature. The late poet donated the 2-square-mile Mead Ranch on Atlas Peak to the Land Trust of Napa County.
May 2, 2024
APA (NASDAQ:APA – Get Free Report) had its price target decreased by investment analysts at Barclays from $40.00 to $38.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target would suggest a potential upside of 28.34% from the stock’s previous […]
May 2, 2024
APA (NASDAQ:APA – Get Free Report) had its target price reduced by analysts at Barclays from $40.00 to $38.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price objective points to a potential upside of 28.34% from the stock’s previous close. A […]